557 related articles for article (PubMed ID: 24036373)
1. Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
Ribeiro R; Yu F; Wen J; Vana A; Zhang Y
Neuroscience; 2013 Dec; 254():427-42. PubMed ID: 24036373
[TBL] [Abstract][Full Text] [Related]
2. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
Wen J; Ribeiro R; Tanaka M; Zhang Y
Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.
de Lago E; Moreno-Martet M; Cabranes A; Ramos JA; Fernández-Ruiz J
Neuropharmacology; 2012 Jun; 62(7):2299-308. PubMed ID: 22342378
[TBL] [Abstract][Full Text] [Related]
4. Arachidonyl trifluoromethyl ketone ameliorates experimental autoimmune encephalomyelitis via blocking peroxynitrite formation in mouse spinal cord white matter.
Vana AC; Li S; Ribeiro R; Tchantchou F; Zhang Y
Exp Neurol; 2011 Sep; 231(1):45-55. PubMed ID: 21683698
[TBL] [Abstract][Full Text] [Related]
5. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death.
Tomiyama K; Funada M
Toxicol Appl Pharmacol; 2014 Jan; 274(1):17-23. PubMed ID: 24211273
[TBL] [Abstract][Full Text] [Related]
7. Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation.
Docagne F; Muñetón V; Clemente D; Ali C; Loría F; Correa F; Hernangómez M; Mestre L; Vivien D; Guaza C
Mol Cell Neurosci; 2007 Apr; 34(4):551-61. PubMed ID: 17229577
[TBL] [Abstract][Full Text] [Related]
8. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
Kong W; Li H; Tuma RF; Ganea D
Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulation of experimental autoimmune encephalomyelitis by the selective CB1 receptor antagonist.
Lou ZY; Zhao CB; Xiao BG
J Neurosci Res; 2012 Jan; 90(1):84-95. PubMed ID: 21922514
[TBL] [Abstract][Full Text] [Related]
10. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
11. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
Rahimi A; Faizi M; Talebi F; Noorbakhsh F; Kahrizi F; Naderi N
Neuroscience; 2015 Apr; 290():279-87. PubMed ID: 25637488
[TBL] [Abstract][Full Text] [Related]
12. The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.
Moreno-Martet M; Feliú A; Espejo-Porras F; Mecha M; Carrillo-Salinas FJ; Fernández-Ruiz J; Guaza C; de Lago E
Mult Scler Relat Disord; 2015 Nov; 4(6):505-11. PubMed ID: 26590655
[TBL] [Abstract][Full Text] [Related]
13. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation.
Linker RA; Mäurer M; Gaupp S; Martini R; Holtmann B; Giess R; Rieckmann P; Lassmann H; Toyka KV; Sendtner M; Gold R
Nat Med; 2002 Jun; 8(6):620-4. PubMed ID: 12042814
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis.
Tambaro S; Casu MA; Mastinu A; Lazzari P
Eur J Pharmacol; 2014 Apr; 729():67-74. PubMed ID: 24561047
[TBL] [Abstract][Full Text] [Related]
15. Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo.
Bernal-Chico A; Canedo M; Manterola A; Victoria Sánchez-Gómez M; Pérez-Samartín A; Rodríguez-Puertas R; Matute C; Mato S
Glia; 2015 Jan; 63(1):163-76. PubMed ID: 25130621
[TBL] [Abstract][Full Text] [Related]
16. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Kokona D; Thermos K
Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
[TBL] [Abstract][Full Text] [Related]
17. Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Fu W; Taylor BK
Neurosci Lett; 2015 May; 595():1-6. PubMed ID: 25849525
[TBL] [Abstract][Full Text] [Related]
18. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
20. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
